Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REMIND: An Investigator Initiated Study Testing the Feasibility of Maintenance Radiotherapy for Patients With Newly Diagnosed Glioblastoma

NCT07831772 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT07831772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07831772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REMIND: An Investigator Initiated Study Testing the Feasibility of Maintenance Radiotherapy for Patients With Newly Diagnosed Glioblastoma
Lead sponsor
University of Minnesota
Phase
Not applicable
Overall status
Recruiting
Start date
August 24, 2026
Completion date
September 20, 2028
Enrollment
4 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, glioblastoma, newly diagnosed glioblastoma